β2-Agonist clenbuterol suppresses bacterial phagocytosis of splenic macrophages expressing high levels of macrophage receptor with collagenous structure

Ken Shirato, Shogo Sato, Madoka Sato, Yoko Hashizume, Kaoru Tachiyashiki, Kazuhiko Imaizumi

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Splenic marginal zone macrophages expressing macrophage receptor with collagenous structure (MARCO) contribute to the clearance of blood-borne pathogens. We determined a splenic adherent cell fraction abundantly containing cells expressing a higher level of MARCO by flow cytometry, and examined the effects of daily administration of an anabolic dose of β2-agonist clenbuterol on the phagocytic capacity of the cells in mice. After 6 weeks of clenbuterol (1.0 mg/kg body weight/d) or vehicle administration to the mice, splenic adherent cells were isolated. These cells were separated into three cell-size subpopulations. Among them, the small-cell subpopulation contained abundantly the cells with markedly higher levels of MARCO and exhibited more intense phagocytic capacity against Escherichia coli, as compared with the other subpopulations. The phagocytic capacity of the small cells was significantly reduced after clenbuterol administration. These results suggest that the utilization of clenbuterol as doping drug impairs bacterial clearance in the spleen.

    Original languageEnglish
    Pages (from-to)475-480
    Number of pages6
    JournalBiological and Pharmaceutical Bulletin
    Volume36
    Issue number3
    DOIs
    Publication statusPublished - 2013 Mar

      Fingerprint

    Keywords

    • β2-agonist
    • Doping
    • Macrophage receptor with collagenous structure
    • Phagocytosis
    • Splenic macrophage

    ASJC Scopus subject areas

    • Pharmaceutical Science
    • Pharmacology

    Cite this